News
Neu Health, a newly released phone app cleared by the FDA this week could help measure early, tell-tale signs of a growing ...
Parkinson's Disease Therapeutics Market The Parkinson's therapeutics market will grow from USD 5.92 Bn in 2024 to USD 12.83 Bn by 2033 at 8 ...
13h
Jacksonville Journal-Courier on MSN'We don't quit': For those living with Parkinson's disease, giving up not an option
For people living with Parkinson's disease in west-central Illinois and beyond, letting the neurodegenerative illness beat ...
AnimalResearch is an essential part of the drug discovery process - they help us test new treatments, and could help change ...
19h
Live Science on MSNDementia: Facts about Alzheimer's and other forms of dementia
Dementia is a group of diseases that involve having trouble with memory, thinking, reasoning and other brain functions. It is ...
British heavy metal legend Ozzy Osbourne died last week at 76 years old, more than 20 years since the “Prince of Darkness” ...
Amyloidosis is an underdiagnosed, progressive group of diseases characterized by the abnormal buildup of a protein called ...
From symptoms to the illness' risk factors — here’s what you need to know about the disease, which can only be detected by ...
12h
The Chosun Ilbo on MSNS. Korean firms showcase breakthroughs in Alzheimer’s drugs, AI diagnostics
South Korean pharmaceutical and biotech companies are presenting their latest Alzheimer’s research at the world’s largest ...
Italian scientists have identified a new function of the DDX11 protein, crucial for cell maintenance and neurodegenerative ...
Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...
Alterity’s cash position on 30 June 2025 was A$40.66M with operating cash outflows for the quarter of A$2.35M. In accordance with ASX Listing Rule 4.7C, payments of A$119k made to related parties and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results